Statement
26 Jan 2024
EB154 individual statement on antimicrobial resistance (AMR)
On 24 January, IFPMA delivered a statement on antimicrobial resistance (AMR) at the WHO 154th Executive Board in Geneva, Switzerland.
Read more
Statement
22 Nov 2023
Joint statement on World Antimicrobial Awareness Week
To mark World Antimicrobial Awareness Week (WAAW) 2023, the International Alliance of Patients’ Organizations (IAPO), the IAPO Patients for Patient Safety Observatory and its AMR Patient Alliance, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the World Medical Association (WMA), the International Council of Nurses (ICN) and International Pharmaceutical Federation (FIP), call for cross-sectoral collaboration to address the growing threat of AMR.
Read more
Statement
18 Oct 2023
IFPMA statement at the 74th Session of the WHO Regional Committee for the Western Pacific
On 18 October 2023 at the 74th Session of the WHO Regional Committee for the Western Pacific in Manila, Philippines, IFPMA submitted a statement on agenda item 11: Health security.
Read more